Fcf Advisors LLC Abb Vie Inc. Transaction History

Fcf Advisors LLC

$422 Million
Q3 2024

A detailed history of Fcf Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fcf Advisors LLC holds 63,371 shares of ABBV stock, worth $11.4 Million. This represents 2.96% of its overall portfolio holdings.

Number of Shares

63,371

Previous 60,816 4.2%

Holding current value

$11.4 Million

Previous $10.4 Million 19.97%

% of portfolio

2.96%

Previous 2.61%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$163.84 - $199.33 $418,611 - $509,288	2,555 Added 4.2%	63,371 $12.5 Million
Q2 2024 Jul 18, 2024	SELL	$154.79 - $180.76 $487,433 - $569,213	-3,149 Reduced 4.92%	60,816 $10.4 Million
Q1 2024 Apr 12, 2024	BUY	$159.82 - $182.1 $810,766 - $923,793	5,073 Added 8.61%	63,965 $11.6 Million
Q4 2023 Jan 04, 2024	BUY	$137.6 - $154.97 $4.76 Million - $5.36 Million	34,588 Added 142.31%	58,892 $9.13 Million
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $161,376 - $186,817	1,208 Added 5.23%	24,304 $3.62 Million
Q2 2023 Jul 19, 2023	SELL	$132.51 - $164.9 $20,009 - $24,899	-151 Reduced 0.65%	23,096 $3.11 Million
Q1 2023 Apr 19, 2023	BUY	$144.61 - $166.54 $1.14 Million - $1.31 Million	7,867 Added 51.15%	23,247 $3.7 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $47,716 - $57,225	-345 Reduced 2.19%	15,380 $2.49 Million
Q3 2022 Oct 12, 2022	SELL	$134.21 - $153.93 $154,341 - $177,019	-1,150 Reduced 6.81%	15,725 $2.11 Million
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $2.5 Million - $3.18 Million	-18,172 Reduced 51.85%	16,875 $2.59 Million
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $2.19 Million - $2.72 Million	16,619 Added 90.18%	35,047 $5.68 Million
Q2 2021 Jul 30, 2021	SELL	$105.21 - $117.21 $143,506 - $159,874	-1,364 Reduced 6.89%	18,428 $2.08 Million
Q1 2021 Apr 06, 2021	BUY	$102.3 - $112.62 $2.02 Million - $2.23 Million	19,792 New	19,792 $2.1 Million
Q4 2020 Jan 12, 2021	SELL	$80.49 - $108.67 $1.75 Million - $2.37 Million	-21,776 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$85.91 - $100.83 $671,128 - $787,683	7,812 Added 55.94%	21,776 $1.91 Million
Q2 2020 Jul 10, 2020	SELL	$73.37 - $98.18 $45,489 - $60,871	-620 Reduced 4.25%	13,964 $1.38 Million
Q1 2020 Apr 21, 2020	SELL	$64.5 - $97.79 $95,976 - $145,511	-1,488 Reduced 9.26%	14,584 $1.06 Million
Q4 2019 Jan 07, 2020	SELL	$72.13 - $90.25 $26,832 - $33,573	-372 Reduced 2.26%	16,072 $1.43 Million
Q3 2019 Oct 09, 2019	BUY	$62.98 - $75.72 $395,955 - $476,051	6,287 Added 61.9%	16,444 $1.25 Million
Q2 2019 Jul 08, 2019	SELL	$65.7 - $83.98 $75,883 - $96,996	-1,155 Reduced 10.21%	10,157 $739,000
Q1 2019 Apr 09, 2019	BUY	$77.14 - $90.79 $41,578 - $48,935	539 Added 5.0%	11,312 $912,000
Q4 2018 Jan 15, 2019	BUY	$77.85 - $96.01 $513,342 - $633,089	6,594 Added 157.79%	10,773 $993,000
Q3 2017 Dec 01, 2017	BUY	$69.85 - $89.22 $291,903 - $372,850	4,179	4,179 $371,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fcf Advisors LLC with notifications on news.

Account